Shelton Capital Management’s Roivant Sciences ROIV Stock Holding History

Shelton Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$517K	Buy	+14,598	New	+$431K	0.01%	360
2026 Q1	–	Sell	-13,285	Closed	-$288K	–	780
2025 Q4	$288K	Hold	13,285	–	–	0.01%	509
2025 Q3	$201K	Hold	13,285	–	–	﹤0.01%	697
2025 Q2	$150K	Hold	13,285	–	–	﹤0.01%	691
2025 Q1	$134K	Hold	13,285	–	–	﹤0.01%	682
2024 Q4	$157K	Hold	13,285	–	–	﹤0.01%	706
2024 Q3	$153K	Sell	13,285 -814	-6%	-$9.27K	﹤0.01%	729
2024 Q2	$149K	Buy	+14,099	New	+$155K	﹤0.01%	700

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Shelton Capital Management's ROIV Position: Q2 2026 in Review

Shelton Capital Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 14,598 shares worth $517K. The stake represents 0.01% of the portfolio and ranks #360 among its holdings. This is a return to the name: Shelton Capital Management previously reported a position in ROIV as recently as Q4 2025.

Shelton Capital Management first reported a position in ROIV in Q2 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Shelton Capital Management held 14,598 shares of Roivant Sciences worth $517K as of Q2 2026.
Roivant Sciences was a new Shelton Capital Management position in Q2 2026.
Roivant Sciences made up 0.01% of Shelton Capital Management's portfolio in Q2 2026, its #360 holding.
Shelton Capital Management first reported a position in Roivant Sciences in Q2 2024 and has held it in 8 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.